Longitudinal biomarker analyses indicate that Flt-1 and IL-15 are elevated within CSF at preclinical, prodromal, and dementia stages of Alzheimer’s disease, and are associated with cortical thinning and subsequent cognitive decline36. Here, FLT1 is linked to Alzheimer disease.